-+ 0.00%
-+ 0.00%
-+ 0.00%

NervGen Pharma Announces Promising Preclinical Results for NVG-291 in Treating Blast-Induced Hearing Loss and Peripheral Nerve Injury

Reuters·08/21/2025 11:31:09

Please log in to view news